Tech Transfer Office announces scientific triumphs
Among those milestones announced by the TTO this year are the following:
| Patent awarded to Xiang Wang laboratory Xiang Wang A CU-Boulder research group led by Xiang Wang, of the Department of Chemistry and Biochemistry, has been awarded a patent for compounds that modulate histone-modifying enzymes, which play critical roles in gene expression, meiosis, and embryonic stem cell self-renewal. The patented compounds have been licensed by Sigma-Aldrich and EMD Millipore as tools to help researchers understand the structures and functions of these enzymes, and may also provide unique opportunities for treating diseases like cancer. For more information, click here. |
| Patent awarded to Thomas Cech research group Thomas Cech A CU-Boulder research group led by BioFrontiers Director and Nobel Laureate Thomas Cech, also a distinguished professor in the Department of Chemistry and Biochemistry, has received a final patent completing a portfolio of intellectual property related to inhibition of telomerase, a naturally occurring enzyme that is linked with proliferation of cancer cells and presents a key target for treatment of many types of cancer. For more information, click here. |
| Campus Technology Transfer Awards announced In April, the University of Colorado Technology Transfer Office presented awards to University of Colorado Boulder researchers and companies who best represented both the spirit of innovation at CU-Boulder and best practices in commercialization of university technologies. Among them were inventors of the year Henry Kapteyn and Margaret Murnane, at left. For more information, click here. |
| Advanced Conductor Technologies commercializing CU high performance superconducting cable Advanced Conductor Technologies and the University of Colorado have completed an exclusive license agreement that allows the company to continue its work developing high-temperature superconducting cables to provide flexible, high-current density power transmission.The high-temp superconducting cable was developed by Danko van der Laan, a senior research associate in the physics department. The key application of Danko’s cables is flexible, high-current density power transmission; they’re currently being optimized by Advanced Conductor Technologies (a CU startup) for nuclear fusion and military applications. For more information, click here. |
| Patent awarded to Steven George's research group Steve George A group of researchers led by Steven George of the Department of Chemistry and Biochemistry and the Department of Chemical & Biological Engineering has been awarded a patent for a process to create ultrathin metal films using atomic layer deposition. The films created using this process are especially well-suited for use as catalysts in fuel cells. For more information, click here. |
| Patent awarded to Yin and Watkins research group Linda Watkins Two CU-Boulder faculty members, Hang Hubert Yin of BioFrontiers and the Department of Chemistry and Biochemistry and Linda Watkins of the Department of Psychology and Neuroscience, recently received a patent for novel drugs modulating the toll-like receptor 4 (TLR4) signaling pathway. These drugs are useful as an independent treatment for chronic pain, and can also be used to help make opioid painkillers (such as Percocet and Vicodin) more effective and less likely to result in addiction and dependency. This technology has been optioned to a publicly-traded biopharma company for further development. For more information, click here. |